Butadiene

Butadiene

SCHEMBL1463631

C1CC1.C=CC=C

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexane SCHEMBL2812401 1.00 TRPA1 (0.33)
Cyclopentane SCHEMBL5066642 1.00
Cyclohexane SCHEMBL2319090 0.85 ALDH1A1 (0.31)
Cyclohexane SCHEMBL8853219 0.82
Butadiene SCHEMBL11854764 0.79 TRPA1 (0.44)
Butadiene SCHEMBL10457929 0.79 TRPA1 (0.44)
Butadiene SCHEMBL250 0.79
Butadiene SCHEMBL11480793 0.79 TRPA1 (0.44)
Butadiene SCHEMBL461643 0.79
Butadiene SCHEMBL22470614 0.76 ALDH1A1 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010009967-A1 Styrene sulfonate cation exchange membrane UBS AG, STAMFORD BRANCH AS COLLATERAL AGENT 2001-07-26 US claimed
EP-1066331-A1 STYRENE SULFONATE CATION EXCHANGE MEMBRANE IONICS INCORPORATED (US) 2001-01-10 EP claimed
WO-1999048940-A1 STYRENE SULFONATE CATION EXCHANGE MEMBRANE IONICS, INCORPORATED (US) 1999-09-30 WO claimed
CN-116669713-A CURCUSONE diterpene and application thereof 普渡研究基金会 2023-08-29 CN disclosed
US-9006231-B2 Cephalotaxus esters, methods of synthesis, and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2015-04-14 US disclosed
US-20140171416-A1 CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 2014-06-19 US disclosed
US-8466142-B2 Cephalotaxus esters, methods of synthesis, and uses thereof SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2013-06-18 US disclosed
US-20110071097-A1 CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2011-03-24 US disclosed
EP-2260041-A2 CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF Sloan Kettering Institute For Cancer Research (US) 2010-12-15 EP disclosed
WO-2009148654-A2 CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 2009-12-10 WO disclosed